Pharmaceuticals and the Elderly: A Comparative Analysis
- 1 March 2000
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
This paper compares and contrasts outpatient pharmaceutical policies for the elderly in seven OECD nations: Australia, Canada, Germany, Japan, New Zealand, the United Kingdom, and the United States. Each country is facing an increasing financial burden due to rapidly growing numbers of elderly citizens, in number and as a percentage of population, and rising drug costs. As a result, they are struggling to balance varying levels of commitment to providing drugs for the elderly with the need to contain costs. Although each country's healthcare systems are unique, the methods that each country is using to control rising pharmaceutical costs are similar. Many countries are gravitating towards the use of last-dollar rather than first-dollar coverage. All provide inpatient pharmaceutical coverage.Keywords
This publication has 24 references indexed in Scilit:
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999
- German government breaks off talks with doctorsBMJ, 1999
- Insurance Coverage for Prescription DrugsMedical Care, 1999
- Perspective: A Drug Benefit: The Necessary Prescription For MedicareHealth Affairs, 1999
- Germany fails to introduce drugs "blacklist"BMJ, 1999
- ‘Manacled Competition’: Market Reforms In German Health CareHealth Affairs, 1999
- Clinical guidelines: Using clinical guidelinesBMJ, 1999
- Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to ActionNew England Journal of Medicine, 1999
- Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelinesBMJ, 1999
- Clinical guidelines---the hidden costsBMJ, 1999